- Mosima Mabunda
- High Wycombe
- United Kingdom
This conversation has closed. Start a new conversation
or join one »
Harmonisation of medicine regulatory bodies across Africa to create a single, unified regulatory body
One of the barriers to drug development in Africa is the fact that drug companies have to file multiple applications with various countries in order to conduct trials or apply for a Marketing Authorisation for a new drug.
This is not only costly but time consuming and with the rising cost of clinical developments, drug companies are focusing their development efforts on markets which are sizeable enough to justify the investment.
Individuals countries in Africa are not big enough to justify the risk of investing in a clinical development program, however if countries within the continent collaborate and establish a unified regulatory body, they can create an attractive Market for drug development thereby improving public health in their respective countries.
